MEA Laparoscopy Devices Market

MEA Laparoscopy Devices Market Size (2023 to 2028)

The size of the laparoscopy devices market in the Middle East and Africa was worth USD 0.82 billion in 2023 and is estimated to be growing at a CAGR of 7.3% from 2023 to 2028 and be worth USD 1.17 billion by 2028.

The market for laparoscopy devices in the Middle East and Africa is driven by the growing incidence of colorectal cancer among the population of MEA. In addition, the growing population suffering from gall bladder problems, Crohn's illness, and obesity are further favoring regional market growth. Furthermore, the growing disposable population income is another major factor fuelling the market growth in this region. In addition, the growing adoption of technological developments in the manufacturing of the laparoscopy devices market in MEA is supporting the market growth.

The adoption of laparoscopy devices is anticipated to be fuelled by the growing usage of these devices in surgical procedures to limit bleeding and rising awareness among healthcare professionals regarding the advantages of using laparoscopy devices, such as high precision. The growing healthcare spending across the MEA region is expected to boost the regional market growth. The increasing investments in the MEA region to promote the healthcare system in this region are expected to support the market's growth rate. In addition, the rising adoption of technological developments to manufacture effective laparoscopic devices is expected to aid regional market growth.

However, poor awareness levels among the public regarding laparoscopic procedures and laparoscopy devices and unfavorable reimbursement policies for laparoscopic equipment are hampering the growth rate of the MEA market. Issues associated with laparoscopic treatments are another major factor inhibiting the market growth in this region. In addition, the scarcity of skilled experts or doctors for laparoscopic operations across MEA further hinders the regional market growth.

This research report on the Middle East and Africa laboratory devices market has been segmented and sub-segmented into the following categories:

By Product Type: 

• Internal Closure Devices
• Hand Access Instruments
• Robotic-Assisted Surgical System
• Laparoscopes
• Direct Energy Systems
• Insufflation Devices

By Therapeutic Application: 

• Colorectal Surgery
• Gynecological Surgery
• General Surgery
• Bariatric Surgery
• Urological Surgery

By End Users: 

• Hospitals
• Clinics
• Ambulatory Surgical Centers

By Country: 

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Faster recovery and shorter hospital stays are major features of laparoscopic treatments in the Middle East and Africa. Laparoscopic device sales are booming due to the popularity of minimally invasive surgeries, technological advancements, and the growing population suffering from colorectal cancer. In addition, the laparoscopic industry has been driven primarily by the rise in morbid obesity on a continental scale. Further, as the number of bariatric procedures to help people lose weight increases, the market is expected to grow.

Africa is forecast to maintain its dominant position in the regional market throughout the forecast period. With the growth in single-incision and other laparoscopic surgeries, we are seeing an increase in the demand for energy devices in the laparoscopy device market. Furthermore, the rising popularity of robot-assisted laparoscopic procedures and the introduction of new laparoscopic devices present an attractive potential for Africa's market growth.

Saudi Arabia is predicted to hold the most significant share of the Middle East and Africa Laparoscopy Devices market, following South Africa. The adoption rate of minimally invasive operations has been increasing due to their benefits, which might boost the market's overall growth throughout the forecast period.

KEY MARKET PLAYERS:

Companies that dominate the MEA Laparoscopy Devices Market in this report are Boston Scientific Corporation, Karl Storz, ConMed, Aesculap, Covidien, Olympus, Intuitive Surgical, Stryker Medtronic, B. Braun Melsungen AG, Ethicon US LLC, and Smith & Nephew.